Sanara MedTech Inc. (SMTI) Financial Statements
Sanara MedTech Inc. (SMTI) reported trailing twelve-month revenue of $109.8M (up 13.0% year on year) and net income of -$32.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $4.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SMTISanara MedTech Inc.Follow SMTI — free
—
Price chart with a free account
- Market cap
- 301.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2 | 1.2 | 1.7 | 2.6 | 3.4 | 5.5 | 6.3 | 5.8 | 11.8 | 15.6 | 24.1 | 45.8 | 65.0 | 86.7 | 103.1 | 109.8 | |
| Gross profit | 1.4 | 0.4 | 0.9 | 1.8 | 2.5 | 4.6 | 5.5 | 5.3 | 10.6 | 14.0 | 21.8 | 39.5 | 57.1 | 78.5 | 95.6 | 102.2 | |
| Research & development | — | — | — | — | — | — | — | — | — | — | 0.6 | 3.4 | 4.1 | 2.8 | 5.1 | 5.0 | |
| Operating income | -5.0 | — | — | — | -1.0 | -0.3 | 0.1 | -0.5 | -2.7 | -5.0 | -7.4 | -12.5 | -4.2 | 1.3 | 7.3 | 8.4 | |
| Pre-tax income | -12.7 | -1.8 | -2.9 | -2.1 | -1.0 | -0.4 | 0.3 | -0.6 | -2.8 | -4.4 | -8.0 | -13.9 | -4.4 | -1.9 | -0.4 | — | |
| Income tax | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | -5.8 | — | 0.0 | — | — | |
| Net income | -12.7 | -1.8 | -4.1 | -2.3 | -1.3 | -0.4 | 0.3 | -0.6 | -2.8 | -4.4 | -7.9 | -7.9 | -4.3 | -9.7 | -37.6 | -32.0 | |
| Diluted EPS ($) | -0.23 | -0.03 | -0.05 | -0.03 | -0.02 | -0.01 | 0.00 | 0.00 | -1.32 | -0.76 | -1.08 | -1.00 | -0.52 | -1.14 | -4.36 | -3.72 | |
| Diluted shares (mn) | — | — | — | — | — | — | 208.6 | 217.2 | 2.1 | 5.7 | 7.3 | 7.9 | 8.3 | 8.5 | 8.6 | — |
USD millions · SEC XBRL
Sanara MedTech Inc. — questions
- What is Sanara MedTech Inc.'s revenue?
- $109.8M over the twelve months to 2026-06-30, up 13.0% year on year, from its 10-Q and 10-K filings.
- What is Sanara MedTech Inc.'s net income?
- -$32.0M over the twelve months to 2026-06-30.
- What is Sanara MedTech Inc.'s free cash flow?
- $4.5M over the twelve months to 2026-06-30.
- What are Sanara MedTech Inc.'s diluted earnings per share?
- $-3.72 over the twelve months to 2026-06-30.
Every figure on this page comes from Sanara MedTech Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.